- Report of Foreign Issuer (6-K)
December 09 2008 - 11:28AM
Edgar (US Regulatory)
FORM
6-K
U.S.
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES
EXCHANGE ACT OF 1934
dated
December 9, 2008
Commission
File Number 0-51373
CHEMGENEX
PHARMACEUTICALS LIMITED
(Exact
Name as Specified in its Charter)
|
N/A
|
|
(Translation
of Registrant’s Name)
|
Pigdons
Road
Waurn
Ponds
P.O. Box
1069, Grovedale
Victoria
3216 Australia
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under
cover of Form 20-F or Form 40-F.
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(1):
o
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(7):
o
Indicate
by check mark whether by furnishing the information contained in this Form, the
registrant is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
If “Yes”
is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b): Not applicable.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused the Report to be signed on its behalf by the undersigned, thereunto
duly authorized.
Date:
December 9, 2008
|
|
CHEMGENEX PHARMACEUTICALSLIMITED
|
|
|
|
|
|
|
|
By:
|
/s/
Greg R. Collier
|
|
|
|
|
Name: Greg
R. Collier
|
|
|
|
|
Title: Managing
Director
|
|
|
|
|
|
|
EXHIBIT
INDEX
|
Exhibit
|
Description
|
|
99.1
|
Release,
December 9, 2008
|
Chemgenex (NASDAQ:CXSP)
Historical Stock Chart
From Apr 2024 to May 2024
Chemgenex (NASDAQ:CXSP)
Historical Stock Chart
From May 2023 to May 2024
